1. Allavena P, Peccatory F, Maggioni D, Erroi A, Sironi M, Colombo N, Lissoni A, Galazka A, Meiers W, Mangioni C (1990) Intraperitoneal recombinant ?-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression of tumor cells. Cancer Res 50:7318?23
2. Benninghoff B, Lehmann V, Eck HP, Droge W (1991) Production of citrulline and ornithine by interferon-?, treated macrophages. Int Immunol 3:413?17
3. Bepler G, Carney DN, Nau MM, Gazdar AF, Minna JD (1986) Additive and differential biological activity of ?-interferon A, difluoromethylornithine, and their combination on established human lung cancer cell lines. Cancer Res 46:3413?19
4. Berenbaum MC (1981) Criteria for analyzing interactions between biologically active agents. Adv Cancer Res 35:269?335
5. Chapekar MS, Glazer RI (1984) Effects of human immune interferon on cell viability, (2?,5) oligoadenylate synthesis, and polyamine-dependent protein phosphorylation in human colon carcinoma cells in vitro. Cancer Res 44:2144?49